Journal
SKELETAL RADIOLOGY
Volume 47, Issue 12, Pages 1595-1606Publisher
SPRINGER
DOI: 10.1007/s00256-018-2965-x
Keywords
Soft-tissue sarcoma; Musculoskeletal sarcoma; Imaging surveillance; Local recurrence; MRI
Funding
- Merck Co., Inc.
Ask authors/readers for more resources
Soft-tissue sarcomas pose diagnostic and therapeutic challenges to physicians, owing to the large number of subtypes, aggressive tumor biology, lack of consensus on management, and controversy surrounding interval and duration of surveillance scans. Advances in multidisciplinary management have improved the care of sarcoma patients, but controversy remains regarding strategies for surveillance following definitive local control. This review provides an updated, comprehensive overview of the current understanding of the risk of local recurrence of soft-tissue sarcoma, by examining the literature based on features such as histological type and grade, tumor size, and resection margin status, with the aim of helping clinicians, surgeons, and radiologists to develop a tailored approach to local imaging surveillance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available